Table 1 Data on all the patients before and after matching
Variables | Unmatched | Matched | ||||
|---|---|---|---|---|---|---|
SCC (n = 5251) | AC/ASC (n = 215) | p-value | SCC (n = 843) | AC/ASC (n = 212) | p-value | |
Age (years) | 55.76 ± 10.81 | 54.45 ± 11.32 | 0.083 | 54.66 ± 11.65 | 54.84 ± 11.50 | 0.842 |
FIGO stage | 0.003 | 0.052 | ||||
I | 21 (0.4%) | 1 (0.4%) | 4 (0.5%) | 1 (0.5%) | ||
II | 8 (0.1%) | 1 (0.4%) | 3 (0.3%) | 1 (0.5%) | ||
IB1 | 101 (1.9%) | 6 (2.8%) | 16 (1.9%) | 6 (2.8%) | ||
IB2 | 79 (1.5%) | 6 (2.8%) | 15 (1.8%) | 6 (2.8%) | ||
IIA | 108 (2.1%) | 3 (1.4%) | 18 (2.1%) | 3 (1.4%) | ||
IIA1 | 255 (4.9%) | 10 (4.7%) | 52 (6.2%) | 9 (4.3%) | ||
IIA2 | 235 (4.5%) | 14 (6.5%) | 27 (3.2%) | 13 (6.1%) | ||
IIB | 1845 (35.1%) | 67 (31.2%) | 293 (34.8%) | 67 (31.6%) | ||
III | 34 (0.6%) | 4 (1.9%) | 2 (0.2%) | 4 (1.9%) | ||
IIIA | 228 (4.3%) | 6 (2.8%) | 31 (3.7%) | 6 (2.8%) | ||
IIIB | 2142 (40.8%) | 78 (36.3%) | 343 (40.7%) | 78 (36.8%) | ||
IV | 61 (1.2%) | 3 (1.4%) | 15 (1.8%) | 3 (1.4%) | ||
IVA | 31 (0.6%) | 4 (1.8%) | 6 (0.7%) | 4 (1.9%) | ||
IVB | 103 (2.0%) | 12 (5.6%) | 18 (2.1%) | 11 (5.2%) | ||
Tumour size | 0.751 | 0.988 | ||||
> 4 cm | 2406 (45.8%) | 96 (44.5%) | 378 (44.8%) | 96 (45.3%) | ||
≤ 4 cm | 1754 (33.4%) | 77 (35.8%) | 299 (35.5%) | 74 (34.9%) | ||
Unknown | 1091 (20.8%) | 42 (19.5%) | 166 (19.7%) | 42 (19.8%) | ||